GC Therapeutics
PrivateLast Round
Series A
Sep 19, 2024
Total Funding Raised
$85M
Company Overview
GC Therapeutics is a biotechnology company that specializes in programming patient-derived stem cells into various cell types using an innovative platform that combines synthetic biology and artificial intelligence to create advanced cell therapies with enhanced manufacturing efficiency and quality.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GC Therapeutics Comparables
Compare GC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Syntax Bio | 88% | |
| Trailhead Biosystems Inc. | 82% | |
| Mogrify | 82% | |
GC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 19, 2024 |
GC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| Cormorant Asset Management | Series A |
| Gaingels | Series A |
| Global Brain Corporation | Series A |
| Medical Excellence Capital | Series A |
| Pear VC | Series A |
| Mubadala Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Kate Haviland appointed as new board chair.
- Apr 1, 2025
Proprietary TFome™ platform developed in Professor George Church's lab.
GC Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GC Therapeutics's valuation, stock price, and market status.